A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Care Network in Patients With MM
Public ClinicalTrials.gov record NCT04730505. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Pilot Trial to Evaluate the My Hematology Oncology Patient Experience (MYHOPE™) for Multiple Myeloma (MM) Digital Care Network in Patients With MM
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
NDS-MM-004 is a multi-center, randomized, pilot trial to evaluate the MyHOPE for multiple myeloma (MM) Platform in patients with MM. The MyHOPE for MM Platform is a validated investigational device manufactured by Amalgam Rx, Inc. and designed to provide patients with a comprehensive set of tools and resources to support the patient throughout their overall experience with MM.
Study identification
- NCT ID
- NCT04730505
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 2 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 4, 2021 (Actual)
- Primary completion
- Jun 21, 2021 (Actual)
- Completion
- Jun 21, 2021 (Actual)
- Last update posted
- Aug 9, 2021
2021
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mitchell Cancer Center, University of South Alabama | Mobile | Alabama | 36604 | — |
| Mayo Cliinic - Scottsdale | Scottsdale | Arizona | 85259 | — |
| University of Arizona | Tucson | Arizona | 85724-507 | — |
| James R Berenson MD Inc | West Hollywood | California | 90069 | — |
| Mayo Clinic - Jacksonville | Jacksonville | Florida | 32224 | — |
| Cancer Specialists of North Florida - Jacksonville | Jacksonville | Florida | 32258-5472 | — |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | — |
| Augusta University - Georgia Cancer Center | Augusta | Georgia | 30912 | — |
| Innovation Clinical Research of the Pacific | Honolulu | Hawaii | 96813 | — |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne | Indiana | 46845 | — |
| American Oncology Partner Maryland | Bethesda | Maryland | 20817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Western Michigan Cancer Center | Kalamazoo | Michigan | 49007 | — |
| Newland Medical Associates, PC | Southfield | Michigan | 48075 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Hattiesburg Clinic | Hattiesburg | Mississippi | 39402 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| NY Cancer and Blood Specialists | Port Jefferson Station | New York | 11776 | — |
| Rochester General Hospital - Lipson Cancer Institute | Rochester | New York | 14621 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27514 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Cone Health Cancer Center | Greensboro | North Carolina | 27403 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| Tri County Hematology Oncology | Canton | Ohio | 44718 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oklahoma Cancer Specialists and Research Institute | Tulsa | Oklahoma | 74146 | — |
| Jefferson Medical Oncology Associates | Philadelphia | Pennsylvania | 19107 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Cancer Care Associates of York | York | Pennsylvania | 17403 | — |
| West Cancer Center | Germantown | Tennessee | 38138 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Community Cancer Trials of Utah | Ogden | Utah | 84405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04730505, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04730505 live on ClinicalTrials.gov.